Balyasny Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.9M | Buy |
|
|||||
|
2025
Q1 | $7.95M | Buy |
|
|||||
|
2024
Q4 | $1.05M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $453K | Sell |
|
|||||
|
2024
Q1 | $2.63M | Buy |
|
|||||
|
2023
Q4 | $2.22M | Sell |
|
|||||
|
2023
Q3 | $13.6M | Buy |
|
|||||
|
2023
Q2 | $5.67M | Buy |
|
|||||
|
2023
Q1 | $4.13M | Sell |
|
|||||
|
2022
Q4 | $15.2M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $288K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $3.84M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $3.12M | Sell |
|
|||||
|
2019
Q2 | $12.2M | Buy |
|
|||||
|
2019
Q1 | $466K | Sell |
|
|||||
|
2018
Q4 | $787K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $243K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $350K | Buy |
|
|||||
|
2017
Q3 | $213K | Sell |
|
|||||
|
2017
Q2 | $1.61M | Sell |
|
|||||
|
2017
Q1 | $2.83M | Sell |
|
|||||
|
2016
Q4 | $19.5M | Buy |
|
|||||
|
2016
Q3 | $7.51M | Sell |
|
|||||
|
2016
Q2 | $13M | Buy |
|
|||||
|
2016
Q1 | $6.36M | Buy |
|
|||||
|
2015
Q4 | $391K | Sell |
|
|||||
|
2015
Q3 | $4.45M | Buy |
|
|||||
|
2015
Q2 | $3.8M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $7.48M | Buy |
|
|||||
|
2013
Q4 | $4.59M | Buy |
|